Raidium
Revolutionizing Radiology with Generative AI
Raidium is transforming the field of radiology by integrating generative artificial intelligence into medical imaging analysis. Founded in 2022 by Dr. Paul Herent and Pierre Manceron, Raidium addresses the increasing demand for radiological services and the complexities of modern examinations. Their AI-powered platform serves as a digital co-pilot for radiologists, enabling real-time, precise analyses and significantly reducing interpretation times.
The platform's capabilities include identifying areas of interest in images and generating detailed reports, thereby enhancing diagnostic accuracy and efficiency. Notably, Raidium's technology can analyze the entire human body, making it particularly effective in complex cases such as metastatic cancers and liver diseases.
Raidium has established strategic partnerships with institutions like AP-HP and various pharmaceutical companies. The company plans to expand its presence internationally, including opening offices in the United States, and is actively pursuing regulatory certifications in Europe and beyond.